These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30996083)

  • 1. Filamentous bacteriophages are associated with chronic
    Burgener EB; Sweere JM; Bach MS; Secor PR; Haddock N; Jennings LK; Marvig RL; Johansen HK; Rossi E; Cao X; Tian L; Nedelec L; Molin S; Bollyky PL; Milla CE
    Sci Transl Med; 2019 Apr; 11(488):. PubMed ID: 30996083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo.
    Secor PR; Michaels LA; Smigiel KS; Rohani MG; Jennings LK; Hisert KB; Arrigoni A; Braun KR; Birkland TP; Lai Y; Hallstrand TS; Bollyky PL; Singh PK; Parks WC
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections.
    Secor PR; Burgener EB; Kinnersley M; Jennings LK; Roman-Cruz V; Popescu M; Van Belleghem JD; Haddock N; Copeland C; Michaels LA; de Vries CR; Chen Q; Pourtois J; Wheeler TJ; Milla CE; Bollyky PL
    Front Immunol; 2020; 11():244. PubMed ID: 32153575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of
    Vanderwoude J; Azimi S; Read TD; Diggle SP
    mBio; 2024 Feb; 15(2):e0310923. PubMed ID: 38171021
    [No Abstract]   [Full Text] [Related]  

  • 6. Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?
    Wolter JM; Bowler SD; McCormack JG
    Aust N Z J Med; 1999 Feb; 29(1):15-21. PubMed ID: 10200808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of
    Evseev P; Bocharova J; Shagin D; Chebotar I
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005892
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
    Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
    Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.
    Fothergill JL; Mowat E; Ledson MJ; Walshaw MJ; Winstanley C
    J Med Microbiol; 2010 Apr; 59(Pt 4):472-481. PubMed ID: 20019149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
    Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
    Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm assembly becomes crystal clear - filamentous bacteriophage organize the
    Secor PR; Jennings LK; Michaels LA; Sweere JM; Singh PK; Parks WC; Bollyky PL
    Microb Cell; 2015 Dec; 3(1):49-52. PubMed ID: 28357315
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
    Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
    [No Abstract]   [Full Text] [Related]  

  • 19. Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding.
    Chen Q; Cai P; Chang THW; Burgener E; Kratochvil MJ; Gupta A; Hargill A; Secor PR; Nielsen JE; Barron AE; Milla C; Heilshorn SC; Spakowitz A; Bollyky PL
    Sci Adv; 2024 May; 10(22):eadl5576. PubMed ID: 38820163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Nov; (11):CD006961. PubMed ID: 26522473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.